Anhedonia Clinical Trial
Official title:
Individualized Neuromodulation for Anhedonic Depression
This program of research constitutes a three-arm, randomized, placebo-controlled trial testing noninvasive brain stimulation for the treatment of anhedonic depression. This trial is part of a larger, three-site study that will be conducted at UCSD, Stanford University, and Cornell University, with the overarching goals to compare competing interventions tested at each site and to combine data that will allow for the creation of an end-to-end model of anhedonic depression. By doing this, the investigators hope to gain insight and lead to the development of brain-behavior biomarkers to identify who is best suited for the different treatment options tested at each site. An additional exploratory objective is phenotyping anhedonic depression from the acquired measures. Anhedonic patients recruited at UCSD will be randomized to one of three treatment arms to receive different forms of accelerated intermittent theta burst stimulation (aiTBS),a novel form of repetitive transcranial magnetic stimulation (rTMS) that is an FDA approved treatment for depression. These arms include: individualized accelerated iTBS (Ind-aiTBS),based on both the frequency of brain responses and electric-field (e-field) modeling of brain bioconductivity; standard accelerated iTBS (Std-aiTBS); and accelerated sham iTBS(sham). Treatment will be delivered on an accelerated schedule, over one week. Additional study sessions will occur both before and after treatment to assess for clinical, neurophysiological, and cognitive measures that will allow for both individualization of treatment and detailed assessment of the effects of the different treatment arms.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Enrolling by invitation |
NCT06035562 -
Promoting Positive Emotional Functioning in Police and Military Populations
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
Withdrawn |
NCT05507385 -
Imagine a Brighter Future: An Intervention to Improve Positive Emotions in Young People
|
N/A | |
Completed |
NCT05383248 -
Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients
|
N/A | |
Suspended |
NCT03715400 -
Mobile Virtual Positive Experiences for Anhedonia
|
N/A | |
Recruiting |
NCT05240352 -
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
|
N/A | |
Recruiting |
NCT03915613 -
Brain Insulin Resistance in Mood Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT04121091 -
Pramipexole to Target "Anhedonic Depression"
|
Phase 2 | |
Completed |
NCT03939676 -
Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity
|
||
Enrolling by invitation |
NCT06285474 -
Investigating LIFUP in Anhedonic Depression
|
N/A | |
Recruiting |
NCT05870501 -
Synaptic Imaging and Network Activity in Treatment Resistant Depression
|
N/A | |
Active, not recruiting |
NCT03848715 -
Sleep and Healthy Aging Research on Depression for Younger Women
|
Phase 1 | |
Completed |
NCT05165394 -
Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
|
Phase 2 | |
Completed |
NCT04647019 -
The Effects of Wild Blueberries on Depressive Symptoms in Young Adults
|
N/A | |
Recruiting |
NCT06075771 -
Dopaminergic Therapy for Anhedonia - 2
|
Phase 4 | |
Completed |
NCT02958228 -
The Effect of Computerized Cognitive Training on Mood and Thinking Style Amongst Patients in Inpatient Settings
|
N/A | |
Recruiting |
NCT05991713 -
Geolocation Positional System (GPS) Experience
|
N/A | |
Completed |
NCT05084924 -
Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia
|
N/A |